Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ZimVie Inc. (ZIMV : NSDQ)
 
 • Company Description   
ZimVie Inc. involved in the Dental and Spine markets which develops, manufactures and delivers a portfolio of products and solutions designed to treat Spine pathologies and support Dental tooth replacement and restoration procedures. ZimVie Inc. is headquartered in Westminster, Colorado.

Number of Employees: 1,770

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.40 Daily Weekly Monthly
20 Day Moving Average: 131,581 shares
Shares Outstanding: 27.85 (millions)
Market Capitalization: $261.77 (millions)
Beta: 2.07
52 Week High: $22.40
52 Week Low: $8.15
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.29% -2.50%
12 Week 0.11% -15.80%
Year To Date -32.62% -36.90%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4555 RIVERSIDE DRIVE
-
PALM BEACH GARDEN,FL 33410
USA
ph: 800-342-5454
fax: -
marissa@gilmartinir.com http://www.zimvie.com
 
 • General Corporate Information   
Officers
Vafa Jamali - President; Chief Executive Officer and Director
Richard Heppenstall - Executive Vice President; Chief Financial Officer
Sandra Schneider - Chief Accounting Officer
Vinit Asar - Director
Sally Crawford - Director

Peer Information
ZimVie Inc. (BJCT)
ZimVie Inc. (CADMQ)
ZimVie Inc. (APNO)
ZimVie Inc. (UPDC)
ZimVie Inc. (IMTIQ)
ZimVie Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 98888T107
SIC: 3843
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 27.85
Most Recent Split Date: (:1)
Beta: 2.07
Market Capitalization: $261.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.00 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 11.90
PEG Ratio: -
Price Ratios
Price/Book: 0.66
Price/Cash Flow: 5.06
Price / Sales: 0.59
EPS Growth
vs. Year Ago Period: 237.50%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -5.24%
vs. Previous Quarter: 0.43%
ROE
06/30/25 - -
03/31/25 - 5.53
12/31/24 - 4.22
ROA
06/30/25 - -
03/31/25 - 2.84
12/31/24 - 1.90
Current Ratio
06/30/25 - -
03/31/25 - 2.14
12/31/24 - 1.92
Quick Ratio
06/30/25 - -
03/31/25 - 1.48
12/31/24 - 1.36
Operating Margin
06/30/25 - -
03/31/25 - 4.91
12/31/24 - 3.69
Net Margin
06/30/25 - -
03/31/25 - -4.40
12/31/24 - -5.74
Pre-Tax Margin
06/30/25 - -
03/31/25 - -3.55
12/31/24 - -5.25
Book Value
06/30/25 - -
03/31/25 - 14.19
12/31/24 - 13.83
Inventory Turnover
06/30/25 - -
03/31/25 - 2.07
12/31/24 - 2.16
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.58
12/31/24 - 0.60
Debt-to-Capital
06/30/25 - -
03/31/25 - 36.68
12/31/24 - 37.46
 

Powered by Zacks Investment Research ©